Showing results (1091-1100 of 3,177) with videos related to
Sort By:
Pageof 318
Translational Oncology|December 1, 2020
Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinomaMárcia Gaião Alves, Márcio Hideki Kodama, Elaine Zayas Marcelino da Silva, et al.Translational Oncology|November 27, 2021
High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanomaLaura Kohtamäki, Mariliina Arjama, Siru Mäkelä, et al.Translational Oncology|November 27, 2021
Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomyXing Zhou, Xiao Jiang, Luzhou Liu, et al.Translational Oncology|October 21, 2022
Recent advances in the field of single-cell proteomicsValdemaras Petrosius, Erwin M SchoofTranslational Oncology|March 18, 2021
IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-cateninYarong Guo, Jun Xu, Qiang Du, et al.Translational Oncology|January 25, 2021
Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinomaDafei Chai, Zichun Zhang, Shang Yuchen Shi, et al.Translational Oncology|January 28, 2021
Phage display screening identifies a prostate specific antigen (PSA)-/lo prostate cancer cell specific peptide to retard castration resistance of prostate cancerYi Sui, Rujian Zhu, Wei Hu, et al.Translational Oncology|November 12, 2021
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cellsNayanendu Saha, Kai Xu, Zhongyu Zhu, et al.Translational Oncology|November 12, 2021
Exposure to Tobacco Smoking Induces a subset of Activated Tumor-resident Tregs in Non-Small Cell Lung CancerYudi Hu, Chaoqun Xu, Jun Ren, et al.Translational Oncology|March 21, 2021
Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resectionYaowen Zhang, Junhui Gao, Anping Zheng, et al.Pageof 318